[Peak inspiratory flow rates attained by asthmatic patients through a dry-powder inhaler of fluticasone propionate].
Fujimori
K
K
Department of Internal Medicine, Niigata Prefectural Shibata Hospital.
Suzuki
E
E
Gejyo
F
F
D000280:Administration, Inhalation; D000730:Androstadienes / Q000008:administration & dosage*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male; D008875:Middle Aged; D011208:Powders; D012123:Pulmonary Ventilation / Q000502:physiology*
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D011208:Powders; D000068298:Fluticasone